ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,026.71
-0.89%
US Tech 100
16,842.82
-1.28%
Dow Jones
37,973.94
-1.27%
Brent Oil
86.89
-0.38%
Bitcoin
64,139.28
-0.22%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Quince Therapeutics Inc (QNCX) Quote

Quince Therapeutics Inc

Quince Therapeutics Inc (QNCX)

NASDAQ
1.03
-0.03
( -2.83% )
Updated: 12:07:16
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.03
Bid
1.03
Ask
1.06
Volume
19,253
1.03 Day's Range 1.06
0.84 52 Week Range 1.74
Market Cap
83.594M
Previous Close
1.06
Open
1.03
Last Trade
600
@
1.03
Last Trade Time
12:03:05
Financial Volume
$ 20,001
VWAP
1.0388
Average Volume (3m)
69,063
Shares Outstanding
42,868,947
Dividend Yield
-
PE Ratio
-2.66
Earnings Per Share (EPS)
-0.73
Revenue
-
Net Profit
-31.39M

About Quince Therapeutics Inc

Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety con... Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
quincetx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was $1.06. Over the last year, Quince Therapeutics shares have traded in a share price range of $ 0.84 to $ 1.74.

Quince Therapeutics currently has 42,868,947 shares outstanding. The market capitalization of Quince Therapeutics is $83.59 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.66.

QNCX Latest News

More News

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease...

April 01 2024
Business Wire

Quince Therapeutics Launches Scientific Advisory Board

World-renowned scientists and clinicians to provide expert insight and advice to support advancement of the company’s lead Phase 3 asset, new indications, and pipeline expansion Quince...

February 22 2024
Business Wire

Form 8-K - Current report

February 15 2024
Edgar (US Regulatory)

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease...

February 15 2024
Business Wire

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease...

February 07 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]

January 05 2024
Edgar (US Regulatory)

Quince Therapeutics to Participate at Investor Events in January 2024

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease...

January 04 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.03311.11990.976911981.07205154CS
4-0.07-6.363636363641.11.140.89968221.01923219CS
12-0.21-16.9354838711.241.420.89690631.14971713CS
260.0687.068607068610.9621.43010.84804801.11170518CS
52-0.49-32.23684210531.521.740.841400611.23761354CS
156-35.77-97.201086956536.8121.980.540161675810.96982648CS
260-18.97-94.8520121.980.540143346115.27983582CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
YYGHYY Group Holding Ltd
$ 4.172
(84.60%)
10.98M
ACONAclarion Inc
$ 0.477
(65.63%)
85.61M
SGBXSafe and Green Holdings Corporation
$ 0.2376
(64.89%)
106.56M
PCSAProcessa Pharmaceuticals Inc
$ 2.265
(39.81%)
60.7M
MNYMoneyHero Ltd
$ 2.45
(36.11%)
4.13M
EJHE Home Household Service Holdings Ltd
$ 0.7733
(-73.43%)
9.45M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.2736
(-35.67%)
12.64M
ATNIATN International Inc
$ 19.26
(-32.94%)
175.3k
BNAIBrand Engagement Network Inc
$ 2.52
(-32.44%)
143.84k
HRYUHanryu Holdings Inc
$ 0.3821
(-27.22%)
1.08M
SGBXSafe and Green Holdings Corporation
$ 0.2376
(64.89%)
106.56M
SQQQProShares UltraPro Short QQQ
$ 12.2847
(4.02%)
86.27M
ACONAclarion Inc
$ 0.477
(65.63%)
85.61M
TSLATesla Inc
$ 164.4799
(1.45%)
62.63M
PCSAProcessa Pharmaceuticals Inc
$ 2.265
(39.81%)
60.7M

QNCX Discussion

View Posts
Monksdream Monksdream 1 month ago
QNCX
👍️0
Monksdream Monksdream 2 months ago
QNCX under $2
👍️0
AKATITUS AKATITUS 4 months ago
Slow climber
👍️0
Monksdream Monksdream 7 months ago
QNCX under $2
👍️0
AKATITUS AKATITUS 9 months ago
Bought some 1.10s
See what happens
👍️0
knrorrel knrorrel 9 months ago
News https://www.stocktitan.net/news/QNCX/quince-therapeutics-to-acquire-ery-del-sp-a-and-its-phase-3-asset-02yx0yj60e08.html
👍️0
AJ Freely AJ Freely 9 months ago
$QNCX - Up 10% Pre-Market/ Current Price $1.75
To Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
👍️0
AJ Freely AJ Freely 9 months ago
$QNCX- Up 26% Pre-Market/ Current Price $1.24
Echo Lake Capital Increase Offer to Acquire Quince Therapeutics
Increases offer to $1.80 per share + CVR to receive 85% of the future net proceeds of Quince as part of the Lighthouse Pharmaceuticals transaction
👍️0
alchemytrader alchemytrader 1 year ago
Happens. Dirty diluting CEOs
👍️0
Backstabbed Backstabbed 1 year ago
Sorry to hear that
👍️0
alchemytrader alchemytrader 1 year ago
not true. i lost my ass trying to swing PSFE HLBZ FUV. took a terrible loss after finally fiving up. Had i held on i would have lost 90-99% of my money.
👍️0
Backstabbed Backstabbed 1 year ago
all about patience. they all run eventually
👍️0
alchemytrader alchemytrader 1 year ago
congrats
👍️0
Backstabbed Backstabbed 1 year ago
$QNCX - added today!
👍️0
Backstabbed Backstabbed 1 year ago
nice. very low PPS here after it hit a high of $1.75 in PM last week
👍️0
Sirpeter Sirpeter 1 year ago
Hi buddy...added it to watch
👍️0
Backstabbed Backstabbed 1 year ago
$QNCX - News out!!! Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
👍️0
tw0122 tw0122 1 year ago
$1.33 running again
👍️0
saj saj 1 year ago
Mid 1.3's nice pop on news
👍️0
makinezmoney makinezmoney 1 year ago
$QNCX: Decent bounce move here..... now 0.74


2 days now back to back....................... it was receding since Summer last ear and now finally going


On WATCH


GO $QNCX
👍️0
cash4 cash4 2 years ago
https://www.otcmarkets.com/filing/html?id=15980132&guid=AKk-kW7ZRh7-B3h
👍️0

Your Recent History

NASDAQ
QNCX
Quince Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved